MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Enveric Biosciences General and Administrative Expenses 2011-2025 | ENVB
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Enveric Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.45 M | 8.85 M | 11.6 M | 20.5 M | 5.44 M | - | - | - | 8.55 M | 5.69 M | 32.8 K | 27.2 K | 22.7 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.5 M | 22.7 K | 6.72 M |
Quarterly General and Administrative Expenses Enveric Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.43 M | 1.22 M | 1.36 M | - | 1.2 M | 1.25 M | 1.89 M | - | 2.08 M | 3.27 M | 2.78 M | - | 3.51 M | 2.5 M | 2.77 M | - | 2.12 M | 2.31 M | 6.47 M | - | 427 K | 717 K | 837 K | - | 2.9 M | 3.3 M | 2.88 M | - | 2.66 M | 2.52 M | 2.88 M | - | 5.28 M | 4.41 M | 2.7 M | - | 1.33 M | 1.98 M | 2.11 M | - | 1.5 M | 490 K | 33.7 K | - | 3.11 K | 505 K | 505 K | - | 4.56 K | 3.89 K | 4.7 K | - | 4.57 K | 4.08 K | 4.04 K | - | 3.69 K | 3.63 K | 11.1 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.47 M | 3.11 K | 1.69 M |